Insider Selling: Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Sells 3,000 Shares of Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 3,000 shares of the business’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of $45.63, for a total value of $136,890.00. Following the transaction, the chief executive officer now owns 37,916 shares of the company’s stock, valued at approximately $1,730,107.08. The trade was a 7.33 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The stock was sold at an average price of $48.53, for a total value of $10,336.89.
• On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44.
• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total value of $126,020.00.

Kewaunee Scientific Price Performance

KEQU traded down $1.54 on Monday, reaching $44.96. 43,557 shares of the company’s stock were exchanged, compared to its average volume of 22,493. Kewaunee Scientific Co. has a twelve month low of $30.82 and a twelve month high of $71.33. The stock has a market cap of $128.36 million, a PE ratio of 7.13 and a beta of 0.71. The stock’s fifty day moving average price is $57.46 and its 200-day moving average price is $47.68. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The company had revenue of $67.17 million during the quarter.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

Institutional Trading of Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Minerva Advisors LLC raised its stake in shares of Kewaunee Scientific by 4.1% in the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock valued at $6,668,000 after acquiring an additional 4,311 shares during the period. Invesco Ltd. bought a new position in Kewaunee Scientific in the 4th quarter worth about $6,545,000. De Lisle Partners LLP increased its stake in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the period. American Century Companies Inc. raised its holdings in shares of Kewaunee Scientific by 18.0% in the 4th quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock worth $2,122,000 after purchasing an additional 5,221 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC raised its holdings in shares of Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after acquiring an additional 891 shares during the period. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.